231 related articles for article (PubMed ID: 33955715)
1. Detection of a mosaic CDKL5 deletion and inversion by optical genome mapping ends an exhaustive diagnostic odyssey.
Cope H; Barseghyan H; Bhattacharya S; Fu Y; Hoppman N; Marcou C; Walley N; Rehder C; Deak K; Alkelai A; ; Vilain E; Shashi V
Mol Genet Genomic Med; 2021 Jul; 9(7):e1665. PubMed ID: 33955715
[TBL] [Abstract][Full Text] [Related]
2. Mutation in an alternative transcript of
Bodian DL; Schreiber JM; Vilboux T; Khromykh A; Hauser NS
Cold Spring Harb Mol Case Stud; 2018 Jun; 4(3):. PubMed ID: 29444904
[TBL] [Abstract][Full Text] [Related]
3. Complex mosaic CDKL5 deletion with two distinct mutant alleles in a 4-year-old girl.
Boutry-Kryza N; Ville D; Labalme A; Calender A; Dupont JM; Touraine R; Edery P; des Portes V; Sanlaville D; Lesca G
Am J Med Genet A; 2014 Aug; 164A(8):2025-8. PubMed ID: 24715584
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestation of CDKL5 deficiency disorder and identified mutations in a cohort of Slovak patients.
Kluckova D; Kolnikova M; Medova V; Bognar C; Foltan T; Svecova L; Gnip A; Kadasi L; Soltysova A; Ficek A
Epilepsy Res; 2021 Oct; 176():106699. PubMed ID: 34229227
[TBL] [Abstract][Full Text] [Related]
5. Two Novel Variants Affecting CDKL5 Transcript Associated with Epileptic Encephalopathy.
Neupauerová J; Štěrbová K; Vlčková M; Sebroňová V; Maříková T; Krůtová M; David S; Kršek P; Žaliová M; Seeman P; Laššuthová P
Genet Test Mol Biomarkers; 2017 Oct; 21(10):613-618. PubMed ID: 28872899
[TBL] [Abstract][Full Text] [Related]
6. Novel CDKL5 mutations were found in patients in China: retrospective investigation in cases of CDKL5-related disorders.
Yan Y; He D; Wu J; Hou R; Sun K; Li L
Ital J Pediatr; 2020 Feb; 46(1):27. PubMed ID: 32111237
[TBL] [Abstract][Full Text] [Related]
7. Somatic mosaicism of a CDKL5 mutation identified by next-generation sequencing.
Kato T; Morisada N; Nagase H; Nishiyama M; Toyoshima D; Nakagawa T; Maruyama A; Fu XJ; Nozu K; Wada H; Takada S; Iijima K
Brain Dev; 2015 Oct; 37(9):911-5. PubMed ID: 25819767
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Optical Genome Mapping With Conventional Diagnostic Methods for Structural Variant Detection in Hematologic Malignancies.
Shim Y; Koo YK; Shin S; Lee ST; Lee KA; Choi JR
Ann Lab Med; 2024 Jul; 44(4):324-334. PubMed ID: 38433573
[TBL] [Abstract][Full Text] [Related]
9. Clinical evolution and epilepsy outcome in three patients with CDKL5-related developmental encephalopathy.
Bernardo P; Ferretti A; Terrone G; Santoro C; Bravaccio C; Striano S; Coppola A; Striano P
Epileptic Disord; 2019 Jun; 21(3):271-277. PubMed ID: 31225800
[TBL] [Abstract][Full Text] [Related]
10. X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.
Terzic B; Cui Y; Edmondson AC; Tang S; Sarmiento N; Zaitseva D; Marsh ED; Coulter DA; Zhou Z
Neurobiol Dis; 2021 Jan; 148():105176. PubMed ID: 33197557
[TBL] [Abstract][Full Text] [Related]
11. Detection of complex chromosome rearrangements using optical genome mapping.
Qu J; Li S; Yu D
Gene; 2023 Oct; 884():147688. PubMed ID: 37543218
[TBL] [Abstract][Full Text] [Related]
12. CDKL5 deficiency causes epileptic seizures independent of cellular mosaicism.
Takahashi S; Takeguchi R; Tanaka R; Fukuoka M; Koike T; Ohtani H; Inoue K; Fukuda M; Kurahashi H; Nakamura K; Tominaga K; Matsubayashi T; Itoh M; Tanaka T
J Neurol Sci; 2022 Dec; 443():120498. PubMed ID: 36417806
[TBL] [Abstract][Full Text] [Related]
13. Analytic Validation of Optical Genome Mapping in Hematological Malignancies.
Pang AWC; Kosco K; Sahajpal NS; Sridhar A; Hauenstein J; Clifford B; Estabrook J; Chitsazan AD; Sahoo T; Iqbal A; Kolhe R; Raca G; Hastie AR; Chaubey A
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137484
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.
Na JH; Shin S; Yang D; Kim B; Kim HD; Kim S; Lee JS; Choi JR; Lee ST; Kang HC
Brain Dev; 2020 Jun; 42(6):438-448. PubMed ID: 32139178
[TBL] [Abstract][Full Text] [Related]
15. [Early-onset epileptic encephalopathy caused by CDKL5 mutation].
Hjalmgrim H; Hansen LK; Ousager LB; Møller RS
Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497626
[TBL] [Abstract][Full Text] [Related]
16. Comparative Benchmarking of Optical Genome Mapping and Chromosomal Microarray Reveals High Technological Concordance in CNV Identification and Additional Structural Variant Refinement.
Barseghyan H; Pang AWC; Clifford B; Serrano MA; Chaubey A; Hastie AR
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895217
[TBL] [Abstract][Full Text] [Related]
17. Hypermotor-tonic-spasms seizure sequence related to CDKL5 deficiency disorder: a typical case.
Appendino JP
Epileptic Disord; 2022 Dec; 24(6):1127-1128. PubMed ID: 35934889
[No Abstract] [Full Text] [Related]
18. Molecular and Synaptic Bases of CDKL5 Disorder.
Zhu YC; Xiong ZQ
Dev Neurobiol; 2019 Jan; 79(1):8-19. PubMed ID: 30246934
[TBL] [Abstract][Full Text] [Related]
19. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
[TBL] [Abstract][Full Text] [Related]
20. Expanding the phenotype of the CDKL5 deficiency disorder: Are seizures mandatory?
MacKay CI; Bick D; Prokop JW; Muñoz I; Rouse J; Downs J; Leonard H
Am J Med Genet A; 2020 May; 182(5):1217-1222. PubMed ID: 32034940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
